CTOR vs GE · $105.2M cap vs P/E 44, rev $45.85B
Citius Oncology, Inc. (CTOR) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
CTOR does not have a complete income-statement cache yet.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
CTOR currently screens at market cap $105.2M. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the CTOR and GE stock pages for the full models.
Not investment advice.